Novel Laboratories, Inc. D.B.A LUPIN FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Last warning letter 2021
Inspections 0 0 OAI
Recalls 1 0 Class I (0%)
Warning letters 1 Latest Jun 11, 2021
510(k) clearances 0 None on file

Novel Laboratories, Inc. D.B.A LUPIN has 1 FDA recall, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. FDA has issued 1 warning letter to Novel Laboratories, Inc. D.B.A LUPIN, the most recent on Jun 11, 2021. FDA has published 1 Form 483 for Novel Laboratories, Inc. D.B.A LUPIN.

What these totals cover: FDA records filed under the name "Novel Laboratories, Inc. D.B.A LUPIN".

Latest recall
D-0726-2021 · Class II · Jul 29, 2021

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls1Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections0Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Novel Laboratories, Inc. D.B.A LUPIN as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Novel Laboratories, Inc. D.B.A LUPIN yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Novel Laboratories, Inc. D.B.A LUPIN FDA Warning Letters

1 warning letter on Jun 11, 2021.

IssuedSubjectIssuing officeClose-out letter
Jun 11, 2021 · Letter on fda.gov CGMP/Finished Pharmaceuticals/AdulteratedOffice of Pharmaceutical Quality Operations Division IApr 19, 2023

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Novel Laboratories, Inc. D.B.A LUPIN Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
Nov 5, 2020 · Document on fda.gov 4833006271438

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

1 recall record on Jul 29, 2021.

NumberClassProductDate
D-0726-2021Class IIGaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured…Jul 29, 2021

Novel Laboratories, Inc. D.B.A LUPIN and the FDA: common questions

Has Novel Laboratories, Inc. D.B.A LUPIN received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Novel Laboratories, Inc. D.B.A LUPIN. The most recent is dated Jun 11, 2021, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".

Has Novel Laboratories, Inc. D.B.A LUPIN received an FDA Form 483?

FDA has published 1 Form 483 for Novel Laboratories, Inc. D.B.A LUPIN in its reading room, the most recent dated Nov 5, 2020. FDA publishes some Form 483s, not all of them.

Has Novel Laboratories, Inc. D.B.A LUPIN had an FDA recall?

Yes. Novel Laboratories, Inc. D.B.A LUPIN has 1 FDA recall on record. The most recent started Jul 29, 2021.

Need more than this page shows? Ask about Novel Laboratories, Inc. D.B.A LUPIN in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.